105 related articles for article (PubMed ID: 30422668)
1. GM1-Binding Conjugates To Improve Intestinal Permeability.
Melkoumov A; St-Jean I; Banquy X; Leclair G; Leblond Chain J
Mol Pharm; 2019 Jan; 16(1):60-70. PubMed ID: 30422668
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells.
Lian T; Ho RJ
Pharm Res; 1997 Oct; 14(10):1309-15. PubMed ID: 9358541
[TBL] [Abstract][Full Text] [Related]
3. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
Yu RK; Usuki S; Itokazu Y; Wu HC
Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
[TBL] [Abstract][Full Text] [Related]
4. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
Blank N; Schiller M; Krienke S; Wabnitz G; Ho AD; Lorenz HM
Immunol Cell Biol; 2007 Jul; 85(5):378-82. PubMed ID: 17325693
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines.
Kiura K; Watarai S; Shibayama T; Ohnoshi T; Kimura I; Yasuda T
Anticancer Drug Des; 1993 Dec; 8(6):417-28. PubMed ID: 8286010
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
Lauer S; Goldstein B; Nolan RL; Nolan JP
Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
[TBL] [Abstract][Full Text] [Related]
7. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.
Liljeqvist S; Ståhl S; Andréoni C; Binz H; Uhlén M; Murby M
J Immunol Methods; 1997 Dec; 210(2):125-35. PubMed ID: 9520296
[TBL] [Abstract][Full Text] [Related]
8. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
Blanco LP; DiRita VJ
Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
[TBL] [Abstract][Full Text] [Related]
9. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
Kirkeby S; Lynge Pedersen AM
Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
[TBL] [Abstract][Full Text] [Related]
10. Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells.
Wands AM; Cervin J; Huang H; Zhang Y; Youn G; Brautigam CA; Matson Dzebo M; Björklund P; Wallenius V; Bright DK; Bennett CS; Wittung-Stafshede P; Sampson NS; Yrlid U; Kohler JJ
ACS Infect Dis; 2018 May; 4(5):758-770. PubMed ID: 29411974
[TBL] [Abstract][Full Text] [Related]
11. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
McCann JA; Mertz JA; Czworkowski J; Picking WD
Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049
[TBL] [Abstract][Full Text] [Related]
12. Glycol chitosan: A stabilizer of lipid rafts in the intestinal brush border.
Danielsen ET; Danielsen EM
Biochim Biophys Acta Biomembr; 2017 Mar; 1859(3):360-367. PubMed ID: 28034633
[TBL] [Abstract][Full Text] [Related]
13. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
Lian T; Bui T; Ho RJ
Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
[TBL] [Abstract][Full Text] [Related]
15. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus.
Pang H; Le PU; Nabi IR
J Cell Sci; 2004 Mar; 117(Pt 8):1421-30. PubMed ID: 14996913
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
Bckström M; Holmgren J; Schödel F; Lebens M
Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
[TBL] [Abstract][Full Text] [Related]
18. Binding of fluorescently labeled cholera toxin subunit B to glycolipids in the human submandibular gland and inhibition of binding by periodate oxidation and by galactose.
Kirkeby S
Biotech Histochem; 2016; 91(1):1-8. PubMed ID: 26472148
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
Mertz JA; McCann JA; Picking WD
Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
[TBL] [Abstract][Full Text] [Related]
20. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array.
Worstell NC; Krishnan P; Weatherston JD; Wu HJ
PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
